Panpan Lin

1.0k total citations
6 papers, 132 citations indexed

About

Panpan Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Panpan Lin has authored 6 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Panpan Lin's work include Gastric Cancer Management and Outcomes (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Panpan Lin is often cited by papers focused on Gastric Cancer Management and Outcomes (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Panpan Lin collaborates with scholars based in China and United States. Panpan Lin's co-authors include Manni Wang, Nansheng Cheng, Xuelei Ma, Xiaoyang Ye, Jing Yang, Xinli Guo, Tae‐Wan Kim, Yuquan Wei, Xiawei Wei and Zhenyu Ding and has published in prestigious journals such as Scientific Reports, British Journal of Cancer and Oncotarget.

In The Last Decade

Panpan Lin

6 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Panpan Lin China	5	63	33	26	26	24	6	132
Mohammed Alghamdi Saudi Arabia	7	58 0.9×	47 1.4×	27 1.0×	36 1.4×	22 0.9×	16	205
Raphaella Ferreira United States	7	30 0.5×	38 1.2×	35 1.3×	37 1.4×	25 1.0×	18	114
Shuichi Kino Japan	9	41 0.7×	42 1.3×	56 2.2×	41 1.6×	15 0.6×	65	260
The Lancet Gastroenterology Hepatology	6	44 0.7×	26 0.8×	13 0.5×	21 0.8×	9 0.4×	8	90
Saqr Alsakarneh United States	7	46 0.7×	62 1.9×	56 2.2×	39 1.5×	10 0.4×	84	185
Wenming Zhou China	6	31 0.5×	13 0.4×	18 0.7×	47 1.8×	29 1.2×	14	157
Bin Quan China	7	49 0.8×	33 1.0×	26 1.0×	6 0.2×	73 3.0×	16	186
Seiji Tsunematsu Japan	6	20 0.3×	37 1.1×	20 0.8×	54 2.1×	8 0.3×	7	93
Xu Gao China	6	31 0.5×	60 1.8×	12 0.5×	37 1.4×	28 1.2×	12	167
Kunlatida Maneenil Thailand	6	87 1.4×	26 0.8×	44 1.7×	14 0.5×	11 0.5×	11	148

Countries citing papers authored by Panpan Lin

Since Specialization

Citations

This map shows the geographic impact of Panpan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panpan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panpan Lin more than expected).

Fields of papers citing papers by Panpan Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panpan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panpan Lin. The network helps show where Panpan Lin may publish in the future.

Co-authorship network of co-authors of Panpan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Panpan Lin. A scholar is included among the top collaborators of Panpan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panpan Lin. Panpan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Chen, Yueyun, Peipei Wang, Yang Hu, et al.. (2024). Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial. British Journal of Cancer. 131(7). 1126–1136. 6 indexed citations

2.

Lin, Panpan, et al.. (2021). HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases. Frontiers in Medicine. 8. 35 indexed citations

3.

Lin, Panpan, Manni Wang, Yuquan Wei, Tae‐Wan Kim, & Xiawei Wei. (2020). Coronavirus in human diseases: Mechanisms and advances in clinical treatment. MedComm. 1(3). 270–301. 20 indexed citations

4.

Chen, Yueyun, Ye Hong, Yang Fu, et al.. (2019). Sequential Administration of EGFR-TKI and Pemetrexed Achieved a Long Duration of Response in Advanced NSCLC Patients with EGFR-mutant Tumours. Asian Pacific Journal of Cancer Prevention. 20(8). 2415–2420. 1 indexed citations

5.

Yang, Jing, Xinli Guo, Manni Wang, et al.. (2017). Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS. Scientific Reports. 7(1). 17166–17166. 64 indexed citations

6.

Xue, Lian, Xiao‐Long Chen, Panpan Lin, et al.. (2016). Impact of capillary invasion on the prognosis of gastric adenocarcinoma patients: A retrospective cohort study. Oncotarget. 7(21). 31215–31225. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact